EV/EBITDA:
-16.25+1.11(+6.39%)Summary
- As of today, NAMS EV/EBITDA is -16.25, with a rise of +1.11 (+6.39%) during the current trading session.
- Over the past year, NAMS EV/EBITDA has increased by +0.64 (+3.79%).
- NAMS EV/EBITDA is now -254.80% below its all-time high of -4.58.
Performance
NAMS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
NAMS EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | +6.4% | -6.4% | -5.3% |
| 1M1 Month | +9.6% | -9.6% | -8.1% |
| 3M3 Months | -41.3% | +66.6% | +46.2% |
| 6M6 Months | -109.7% | +125.5% | +74.5% |
| YTDYTD | -46.0% | +69.5% | +37.2% |
| 1Y1 Year | +3.8% | +48.3% | +42.8% |
| 5Y5 Years | - | - | - |
NAMS EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | -15.99 | -1.6% | -19.71 | +17.6% |
| 3M | 3-Month | -11.50 | -41.3% | -19.71 | +17.6% |
| 6M | 6-Month | -6.41 | -153.5% | -19.71 | +17.6% |
| 1Y | 1-Year | -4.58 | -254.8% | -19.71 | +17.6% |
| 3Y | 3-Year | -4.58 | -254.8% | -284.06 | +94.3% |
| 5Y | 5-Year | -4.58 | -254.8% | -1189 | +98.6% |
| All-Time | All-Time | -4.58 | -254.8% | -1189 | +98.6% |
NAMS EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -16.25(-46.0%) |
| 2024 | -11.13(+93.6%) |
| Date | Value |
|---|---|
| 2022 | -174.80(-72.8%) |
| 2021 | -101.16 |
FAQ
- What is NewAmsterdam Pharma Company N.V. EV/EBITDA?
- What is the all-time high EV/EBITDA for NewAmsterdam Pharma Company N.V.?
- What is NAMS EV/EBITDA year-to-date change?
- What is NewAmsterdam Pharma Company N.V. EV/EBITDA year-on-year change?
What is NewAmsterdam Pharma Company N.V. EV/EBITDA?
The current EV/EBITDA of NAMS is -16.25
What is the all-time high EV/EBITDA for NewAmsterdam Pharma Company N.V.?
NewAmsterdam Pharma Company N.V. all-time high EV/EBITDA is -4.58
What is NAMS EV/EBITDA year-to-date change?
NewAmsterdam Pharma Company N.V. EV/EBITDA has changed by -5.12 (-46.00%) since the beginning of the year
What is NewAmsterdam Pharma Company N.V. EV/EBITDA year-on-year change?
Over the past year, NAMS EV/EBITDA has changed by +0.64 (+3.79%)